Bella Pharmaceuticals, Inc., Glenview, IL
Is Bella Pharmaceuticals, Inc. registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility, with FDA’s note “Ceased Compounding Operations”.
Does Bella Pharmaceuticals, Inc. hold a Illinois pharmacy license?
No license with this exact name and city was found in the Illinois Department of Financial and Professional Regulation file dated Nov 13, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed.
Has Bella Pharmaceuticals, Inc. had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Feb 11, 2019) and 1 FMD-145 letter (Aug 3, 2020) for Bella Pharmaceuticals, Inc. State board actions: no Illinois Department of Financial and Professional Regulation action under this exact name and city was found in the board’s license dataset (actions dated May 23, 1980 to Sep 10, 2026) on Nov 13, 2026.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Bella Pharmaceuticals, Inc.
- Location
- Glenview, IL
- Type as FDA labels it
- 503A
- FDA’s note
- Ceased Compounding Operations
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 0
- Warning letters on FDA’s actions page
- 1
- Latest action on that page
- Aug 3, 2020
- FDA Data Dashboard inspections
- 1 inspection: 1 OAI; 1 published Form 483
- State board records
- No exact match
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Bella Pharmaceuticals, Inc., a 503A facility, with 2 dated actions.
| Document | |||
|---|---|---|---|
| Aug 3, 2020 | FMD-145 letter | FMD-145 Letter Issued 08/03/2020 | Not linked by FDA |
| Feb 11, 2019 | Warning letter | Warning Letter (02/11/2019) | FDA copy (archived) |
A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Bella Pharmaceuticals, Inc., Glenview, IL (FEI number 3013442632), matched to this page by exact name, city and state. It lists 1 inspection: 1 OAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Jul 18, 2017 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3013442632 | 1018407 |
Form 483s FDA has published for this site
- Aug 3, 2017: Form 483 to Bella Pharmaceuticals, Inc., published Jan 17, 2024. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA links 1 Form 483 PDF for Bella Pharmaceuticals, Inc., but no observation text is shown, for the reasons below.
Linked 483s whose text is not shown
- Aug 3, 2017: FDA document 106097: the PDF is a scanned image with no readable text.
State board of pharmacy records
No license with this exact name and city was found in the Illinois Department of Financial and Professional Regulation file dated Nov 13, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. Board file.
What this covers: Discipline IDFPR publishes with each license in the dataset (case number, action, start date and the department’s one-line reason), worded as the department gives it. The dataset marks 931 of these licenses as ever disciplined; some of them carry no action in the dataset. Actions in the data are dated May 23, 1980 to Sep 10, 2026.
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- Illinois Department of Financial and Professional Regulation license file
Records last pulled Nov 15, 2026. Every entry links to the original public record.